Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look for. ResMed beat analysts’ revenue expectations by 1% last quarter ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...

ResMed has appointed Salli Schwartz as the new Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings over two decades of experience from roles in finance at health tech and ...

ResMed RMD is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that ResMed ...

SAN DIEGO, April 21, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the ...

Throughout the last three months, 5 analysts have evaluated ResMed RMD, offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary of their recent ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea. The NightOwl testing device, about the size of a quarter, is worn on the ...

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will lead Resmed’s global investor relations function and ...